Tag:
Linjeta
Latest Headlines
Latest Headlines
Biodel shares plunge after FDA demands two new Ph3 trials
After fretting for months that Biodel ( BIOD ) didn't have the data needed to gain an approval for its fast-acting insulin Linjeta, analysts discovered this morning that the FDA is requiring the
